Top of Page
Skip main navigation

Research Studies

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Gulf War illness (GWI), as well as other fatigue-related illnesses are poorly understood. Individuals can experience severe, long-lasting fatigue, which cannot be properly explained through extensive diagnostic procedures. Our research partnership with the CDC, Miami VA, NIH, other universities and private institutions furthers the understanding in the medical community as to how these illnesses affect their patients which can be used to develop a better understanding for improved health care. 

Your participation will be contributing to the knowledge and understanding of these illnesses. With your help, people with ME/CFS, GWI and other fatiguing illnesses may be better treated in the future. We thank you in advance for your participation and continued support.

Institute for Neuro-Immune Medicine Research Studies

Clinical Nutrition Profile for ME/CFS

Researchers will be able to create a profile of individuals with ME/CFS based on their dietary intake information and nutritional biomarkers, merged with other clinically relevant data. The CNP created could aid in identifying disease targets, improving overall organ system function, allowing the body to heal and potentially resetting homeostatic function. We are no longer recruiting for this study.

 

Immune Reactivity to Gluten in Patients with Rheumatoid Arthritis

This is a pilot study that will evaluate the frequency of gluten sensitivity in a sample of patients with the diagnosis of Seropositive Rheumatoid Arthritis (RA). Researchers will focus on antibody-mediated immune responses in three isotypes: IgA, IgE and IgG by testing serum samples from the blood of RA patients for the presence of total and wheat-specific antibodies.
For more information, please email MKesselman@nova.edu.

ME/CFS Genes Study

We are recruiting ME/CFS patients AND healthy controls for this completely web-based study to create a one of a kind genetic database for individuals with ME/CFS. Interested research participants must go to the link below and email MECFSGenes@Nova.edu.

Gulf War Illness Research Studies & Trials

For more information, please contact us at 305-575-7648 or email VHAMIAGWI@va.gov.

Clinical Trial: Understanding Gulf War Illness

The purpose of this study is to test the safety, effectiveness and biological response to two medications (Etanercept followed by Mifepristone) in changing the body's sick responseof GWI into a more permanently healthy condition. This study is located at the Miami VA Medical Center. We are recruiting male Veterans with Gulf War Illness between 45-70 years of age. For more information, please contact us at 305-575-7648 or email VHAMIAGWI@va.gov.

Gulf War Illness Women's Study

In this study, we are using microarray, a technique which measures expression levels of large numbers of genes, to help better understand and identify the likely causes of Gulf War Illness. This method allows researchers to study different genes that affect how the body reacts to rest and exercise and how these differences affect the immune system, endocrine system and brain. Locations: Miami VA Medical Center & University of Miami. We are recruiting women Veterans with Gulf War Illness and women Gulf War-era sedentary Veterans. For more information, please contact us at 305-575-7648 or email VHAMIAGWI@va.gov.

Gulf War Illness: From Cells to Therapy 

This is a systematic assessment and characterization of the therapeutic effects of drugs that impact a specific list of therapeutic targets which is based on prior research. This study is located at Miami VA Medical Center. We are recruiting ALL Veterans with Gulf War Illness and Gulf War era healthy controls. For more information, please contact us at 305-575-7648 or email VHAMIAGWI@va.gov.

GWI Survey Study: Take our Survey!

Nova Southeastern University’s Institute for Neuro-Immune Medicine is conducting a brief survey to learn more about certain unexplained illnesses that may be associated with the men and women in service during the Gulf War, Operation Desert Storm/Desert Shield and Operation Iraqi Freedom. For more information regarding this survey, please follow the link to: NSU/INIM Gulf War Survey.

Nutraceutical Study for Gulf War Illness: CoQ10

The purpose of this study is to determine if treatment with ubiquinol, a form of coenzyme Q10, improves the physical function of men and women Veterans suffering from Gulf War illness. We are Located at the Miami VA Medical Center, VA Boston Healthcare System, Minneapolis VA Health Care System and the James J. Peters VA Medical Center. We are recruiting ALL Gulf War Veterans. For more information, please contact us at 305-575-7648 or email VHAMIAGWI@va.gov

Nutraceutical Study for Gulf War Illness: Liposomal 

Two natural supplements (Curcumin and Glutathione) have been shown to quiet inflammation. In this study, researchers will test to see which supplements, if any, are beneficial in Gulf War Illness. This study is located at the Miami VA Medical Center. We are recruiting ALL Veterans with Gulf War Illness between 35-70 years of age. For more information, please contact us at 305-575-7648 or email VHAMIAGWI@va.gov. 

Gulf War Illness Consortium 

The Gulf War Illness consortium is conducting several clinical trials and interventions aimed at understanding Gulf War Illness. These clinical trials are funded by the Department of Defense (DoD) and will be conducted at NSU's Institute for Neuro-Immune Medicine, Boston University, RTI International, Bronx VAMC, New Jersey War Related Illness and Injury Study Center (WRIISC), and the California U.S. Department of Veterans Affairs War Related Illness and Injury Study Center (WRIISC). For more information, please contact us at 305-575-7648 or email VHAMIAGWI@va.gov.

Nutraceutical for GWI Associated Cognitive Dysfunction & Biological Response

Phase I will assess safety, feasibility, initial evidence of effectiveness and biological response of a nutraceutical as an evidenced cognitive enhancing agent, with multi-mechanistic action.

Phase I Study: Antioxidant Combination Therapy for CNS Recovery

Phase I aims to compare the ability of different antioxidants to cross the blood brain barrier and change the oxidative stress state in the central nervous system (CNS) as measured by MRS.

Phase II Study: Antioxidant Combination Therapy for CNS Recovery

Phase II will build on our findings from Phase I by combining the best of the two antioxidants with the anticipation that the combination will work synergistically and help to restore CNS functions and reset homeostasis.

Phase I Study: TNF & Glucocorticoid Antagonist for GWI Associated Multi-Symptom Disease Hemostasis Reset

This dosage finding phase I study will evaluate the safety, effectiveness and biological response to two medications (TNF and Glucocorticoid receptor antagonists) in changing your bodies “sick response” of GWI into a more permanently healthy condition.

Phase II Study: TNF & Glucocorticoid Antagonist for GWI Associated Multi-Symptom Disease Hemostasis Reset

Phase II will follow the most effective of the two potential dosing strategies from Phase I for TNF and Glucocorticoid receptor Antagonists in changing your bodies “sick response” of GWI into a more permanently healthy condition.

Past Studies

CDC Multisite Study

The INIM conducted a multisite research study on behalf of the CDC to better understand the nature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with the goal of improving quality of care available to ME/CFS patients. These studies were conducted at the INIM's Davie and Kendall locations. 

 

Gulf War Illness: Boston Brain Immune Interactions Study

The purpose of the study was to gain a better understanding of the causes of the symptoms associated with Gulf War Illness.

Return to top of page